BACKGROUND: Lung cancer screening (LCS) via chest computed tomography (CT) scans can save lives by identifying early-stage tumors. However, most smokers die of comorbid smoking-related diseases. LCS scans contain information about smoking-related conditions that is not currently systematically assessed. Identifying these common comorbid diseases on CT could increase the value of screening with minimal impact on LCS programs. We determined the prevalence of 3 comorbid diseases from LCS eligible scans and quantified related adverse outcomes. METHODS: We studied COPD Genetic Epidemiology study (COPDGene®) participants (n=4078) who met criteria for LCS screening at enrollment (age > 55 years, and < 80 years, > 30 pack years smoking, current smoker or former smoker within 15 years of smoking cessation). CT scans were assessed for coronary artery calcification (CAC), emphysema, and vertebral bone density. We tracked the following clinically significant events: myocardial infarctions (MIs), strokes, pneumonia, respiratory exacerbations, and hip and vertebral fractures. RESULTS: Overall, 77% of eligible CT scans had one or more of these diagnoses identified. CAC (> 100 mg) was identified in 51% of scans, emphysema in 44%, and osteoporosis in 54%. Adverse events related to the underlying smoking-related diseases were common, with 50% of participants reporting at least one. New diagnoses of cardiovascular disease, emphysema and osteoporosis were made in 25%, 7% and 46%, of participants respectively. New diagnosis of disease was associated with significantly more adverse events than in participants who did not have CT diagnoses for both osteoporosis and cardiovascular risk. CONCLUSIONS: Expanded analysis of LCS CT scans identified individuals with evidence of previously undiagnosed cardiovascular disease, emphysema or osteoporosis that corresponded with adverse events. LCS CT scans can potentially facilitate diagnoses of these smoking-related diseases and provide an opportunity for treatment or prevention. JCOPDF
BACKGROUND: Lung cancer screening (LCS) via chest computed tomography (CT) scans can save lives by identifying early-stage tumors. However, most smokers die of comorbid smoking-related diseases. LCS scans contain information about smoking-related conditions that is not currently systematically assessed. Identifying these common comorbid diseases on CT could increase the value of screening with minimal impact on LCS programs. We determined the prevalence of 3 comorbid diseases from LCS eligible scans and quantified related adverse outcomes. METHODS: We studied COPD Genetic Epidemiology study (COPDGene®) participants (n=4078) who met criteria for LCS screening at enrollment (age > 55 years, and < 80 years, > 30 pack years smoking, current smoker or former smoker within 15 years of smoking cessation). CT scans were assessed for coronary artery calcification (CAC), emphysema, and vertebral bone density. We tracked the following clinically significant events: myocardial infarctions (MIs), strokes, pneumonia, respiratory exacerbations, and hip and vertebral fractures. RESULTS: Overall, 77% of eligible CT scans had one or more of these diagnoses identified. CAC (> 100 mg) was identified in 51% of scans, emphysema in 44%, and osteoporosis in 54%. Adverse events related to the underlying smoking-related diseases were common, with 50% of participants reporting at least one. New diagnoses of cardiovascular disease, emphysema and osteoporosis were made in 25%, 7% and 46%, of participants respectively. New diagnosis of disease was associated with significantly more adverse events than in participants who did not have CT diagnoses for both osteoporosis and cardiovascular risk. CONCLUSIONS: Expanded analysis of LCS CT scans identified individuals with evidence of previously undiagnosed cardiovascular disease, emphysema or osteoporosis that corresponded with adverse events. LCS CT scans can potentially facilitate diagnoses of these smoking-related diseases and provide an opportunity for treatment or prevention. JCOPDF
Authors: Joyce D Schroeder; Alexander S McKenzie; Jordan A Zach; Carla G Wilson; Douglas Curran-Everett; Douglas S Stinson; John D Newell; David A Lynch Journal: AJR Am J Roentgenol Date: 2013-09 Impact factor: 3.959
Authors: Caroline Chiles; Fenghai Duan; Gregory W Gladish; James G Ravenel; Scott G Baginski; Bradley S Snyder; Sarah DeMello; Stephanie S Desjardins; Reginald F Munden Journal: Radiology Date: 2015-03-09 Impact factor: 11.105
Authors: Elizabeth A Regan; Tiffany A Radcliff; William G Henderson; Diane C Cowper Ripley; Matthew L Maciejewski; W Bruce Vogel; Evelyn Hutt Journal: COPD Date: 2012-12-28 Impact factor: 2.409
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Timothy R Church; William C Black; Denise R Aberle; Christine D Berg; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; David S Gierada; Gordon C Jones; Irene Mahon; Pamela M Marcus; JoRean D Sicks; Amanda Jain; Sarah Baum Journal: N Engl J Med Date: 2013-05-23 Impact factor: 91.245
Authors: Song Soo Kim; Kunihiro Yagihashi; Douglas S Stinson; Jordan A Zach; Alexander S McKenzie; Douglas Curran-Everett; Emily S Wan; Edwin K Silverman; James D Crapo; David A Lynch Journal: Chronic Obstr Pulm Dis Date: 2014
Authors: Elisabeth A P M Romme; John T Murchison; Lisa D Edwards; Edwin van Beek; David M Murchison; Erica P A Rutten; Frank W J M Smeenk; Michelle C Williams; Emiel F M Wouters; William MacNee Journal: J Bone Miner Res Date: 2013-06 Impact factor: 6.741
Authors: Albert L Siu; Kirsten Bibbins-Domingo; David C Grossman; Karina W Davidson; John W Epling; Francisco A R García; Matthew Gillman; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Diane M Harper; William R Phillips; Maureen G Phipps; Michael P Pignone Journal: JAMA Date: 2016-04-05 Impact factor: 56.272
Authors: Michelle C Williams; John T Murchison; Lisa D Edwards; Alvar Agustí; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; Bruce E Miller; Steve Rennard; Edwin K Silverman; Ruth Tal-Singer; Jørgen Vestbo; Emiel Wouters; Julie C Yates; Edwin J R van Beek; David E Newby; William MacNee Journal: Thorax Date: 2014-01-28 Impact factor: 9.139
Authors: Charles R Hatt; Andrea S Oh; Nancy A Obuchowski; Jean-Paul Charbonnier; David A Lynch; Stephen M Humphries Journal: Radiol Cardiothorac Imaging Date: 2021-04-22
Authors: Wassim W Labaki; Meng Xia; Susan Murray; Charles R Hatt; Abdullah Al-Abcha; Michael C Ferrera; Catherine A Meldrum; Lauren A Keith; Craig J Galbán; Douglas A Arenberg; Jeffrey L Curtis; Fernando J Martinez; Ella A Kazerooni; MeiLan K Han Journal: Chest Date: 2020-12-14 Impact factor: 9.410
Authors: Aleksandra Undrunas; Piotr Kasprzyk; Aleksandra Rajca; Krzysztof Kuziemski; Witold Rzyman; Tomasz Zdrojewski Journal: BMJ Open Date: 2022-04-11 Impact factor: 2.692